Based on the NanoVibronix Inc stock forecast from 0 analysts, the average analyst target price for NanoVibronix Inc is not available over the next 12 months. NanoVibronix Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of NanoVibronix Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, NanoVibronix Inc’s stock price was USD 5.97. NanoVibronix Inc’s stock price has changed by -21.45% over the past week, +35.99% over the past month and -27.16% over the last year.
No recent analyst target price found for NanoVibronix Inc
No recent average analyst rating found for NanoVibronix Inc
Company Overview NanoVibronix Inc
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York. Read Less
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based ...Read More
Frequently Asked Questions About NanoVibronix Inc (NAOV) Stock
Stock Target Advisor's fundamental analysis for NanoVibronix Inc's stock is Bearish.
Unfortunately we do not have enough data on NAOV's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on NAOV's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on NAOV's stock to indicate if its overvalued.
The last closing price of NAOV's stock was USD 5.97.
The most recent market capitalization for NAOV is USD 1.87M.
Unfortunately we do not have enough analyst data on NAOV's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains NanoVibronix Inc's stock.
As per our most recent records NanoVibronix Inc has 10 Employees.
NanoVibronix Inc's registered address is 525 Executive Boulevard, Elmsford, NY, United States, 10523.
You can get more information about it from NanoVibronix Inc's website at https://www.nanovibronix.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About NanoVibronix Inc (NAOV) Stock
Stock Target Advisor's fundamental analysis for NanoVibronix Inc's stock is Bearish.
Unfortunately we do not have enough data on NAOV's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on NAOV's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on NAOV's stock to indicate if its overvalued.
The last closing price of NAOV's stock was USD 5.97.
The most recent market capitalization for NAOV is USD 1.87M.
Unfortunately we do not have enough analyst data on NAOV's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains NanoVibronix Inc's stock.
As per our most recent records NanoVibronix Inc has 10 Employees.
NanoVibronix Inc's registered address is 525 Executive Boulevard, Elmsford, NY, United States, 10523.
You can get more information about it from NanoVibronix Inc's website at https://www.nanovibronix.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NAOV !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
